Gerald Yacobucci, MD
Orthopaedic Surgery · Phoenix, AZNPI 1649257304
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Goode Surgical Inc at 53.4% of the total. Reporting peaked in 2020 at $2,182 and has fallen 99.2% since, to $18 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in AZ, where the typical reported total is $4,792.
Across 94 payments — averaging $39.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Goode Surgical Inc$2K
- Arthrex$739
- Amgen$405
- Johnson & Johnson$171
- Ferring Pharmaceuticals Inc.$82
- Fidia Pharma USA Inc.$72
- plus $276 from 11 others
What the payments were for
- Speaking & faculty fees$2,00053%
- Travel & lodging$2477%
- Food & beverage$1,49840%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Goode Surgical Inc | 1 | $2,000 |
| Arthrex | 8 | $739 |
| Amgen | 53 | $405 |
| Johnson & Johnson(2 entities) | 6 | $171 |
| Ferring Pharmaceuticals Inc. | 5 | $82 |
| Fidia Pharma USA Inc. | 5 | $72 |
| Zyla Life Sciences, Inc. | 3 | $44 |
| Smith+Nephew | 1 | $43 |
| Vericel Corporation | 2 | $34 |
| Orthogenrx Inc. | 2 | $33 |
| Bioventus LLC | 2 | $32 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Conformis, Inc. | 1 | $14 |
| Pacira Therapeutics, Inc. | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $11 |
| Electronic Waveform Lab, Inc. | 1 | $9 |
How this compares
$3,744 in reported general payments places this provider in the 45th percentile of 377 orthopaedic surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 252 | $1,931 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Phoenix
- Evan LedermanPhoenix$12M
- James ChowPhoenix$6.1M
- Michael McKeePhoenix$3.4M
- Henry ClarkePhoenix$1.9M
- Samuel HarmsenPhoenix$735K
- Anthony HedleyPhoenix$415K
- Matthew SeidelPhoenix$397K
- David OttPhoenix$380K
- Michael WilminkPhoenix$347K
- Judd CummingsPhoenix$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.